Laparoscopic surgery is gaining currency in the field of oncologic care, particularly for colorectal and gynecologic cancers. This innovation could be used either for staging purpose and therefore could steer global therapeutic options or for surgical management only. Increase knowledge and skills lead to an increase in the number and rate of the women this innovation could be offered. The project team observed a shift from traditional surgical management (abdominal radical surgery) towards laparoscopic with a focus on lymphadenectomy. This innovation however increases some costs (the surgical stage) but decrease some others (the post surgical stage). Foreseeing the pace of the dissemination needs to have objective and reliable data about who had access to laparoscopic surgery and who didn't (and why) and accurate assessment of related costs. This program will focus on uterine cancer (both cervix and corpus).
Study Type
OBSERVATIONAL
Enrollment
343
Institut Paoli-Calmettes
Marseille, Bouches-du Rhône, France
Cost comparison between Conventional vs Robotic-Assisted Laparoscopy
The following costs were included:Equipment costs,Instrument costs,Operating room costs,Hospital stay
Time frame: 2 years
Comparison of the effectiveness of procedures (Conventional vs Robotic-Assisted Laparoscopy)
Comparison of the effectiveness of procedures will take into account conversion rate, complications rate, metastatic and pelvic relapse
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.